103 related articles for article (PubMed ID: 11418382)
1. Diminished T-cell recovery after CD34(+) selected autologous peripheral blood stem cell transplantation increases the risk of cytomegalovirus infection.
Nishio M; Koizumi K; Endo T; Fujimoto K; Koike T; Sawada K
Haematologica; 2001 Jun; 86(6):667-8. PubMed ID: 11418382
[No Abstract] [Full Text] [Related]
2. Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection.
Peggs KS; Verfuerth S; Pizzey A; Khan N; Moss P; Goldstone AH; Yong K; Mackinnon S
Biol Blood Marrow Transplant; 2003 Mar; 9(3):198-205. PubMed ID: 12652471
[TBL] [Abstract][Full Text] [Related]
3. Number of viable CD34(+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation.
Allan DS; Keeney M; Howson-Jan K; Popma J; Weir K; Bhatia M; Sutherland DR; Chin-Yee IH
Bone Marrow Transplant; 2002 Jun; 29(12):967-72. PubMed ID: 12098064
[TBL] [Abstract][Full Text] [Related]
4. Dendritic cell recovery after autologous stem cell transplantation.
Damiani D; Stocchi R; Masolini P; Michelutti A; Sperotto A; Geromin A; Skert C; Cerno M; Michieli M; Baccarani M; Fanin R
Bone Marrow Transplant; 2002 Sep; 30(5):261-6. PubMed ID: 12209346
[TBL] [Abstract][Full Text] [Related]
5. Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
Martino R; Rovira M; Carreras E; Solano C; Jorge S; De La Rubia J; Caballero MD; de Oteyza JP; Zuazu J; Moraleda JM; Ojeda E; Ferrá C; Serrano D; De La Cámara R; Urbano-Ispízua A; Brunet S;
Haematologica; 2001 Oct; 86(10):1075-86. PubMed ID: 11602414
[TBL] [Abstract][Full Text] [Related]
6. Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Kohno K; Nagafuji K; Tsukamoto H; Horiuchi T; Takase K; Aoki K; Henzan H; Kamezaki K; Takenaka K; Miyamoto T; Teshima T; Harada M; Akashi K
Transpl Infect Dis; 2009 Aug; 11(4):318-23. PubMed ID: 19453993
[TBL] [Abstract][Full Text] [Related]
7. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
[TBL] [Abstract][Full Text] [Related]
8. Disseminated toxoplasmosis after CD34+-selected autologous peripheral blood stem cell transplantation.
Nakane M; Ohashi K; Tominaga J; Akiyama H; Hiruma K; Sakamaki H
Haematologica; 2000 Mar; 85(3):334-5. PubMed ID: 10702835
[No Abstract] [Full Text] [Related]
9. Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation.
de Boer F; Dräger AM; Pinedo HM; Kessler FL; van der Wall E; Jonkhoff AR; van der Lelie J; Huijgens PC; Ossenkoppele GJ; Schuurhuis GJ
Bone Marrow Transplant; 2002 Feb; 29(3):249-55. PubMed ID: 11859398
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34(+) cells.
Miura Y; Ueda M; Takami A; Shiobara S; Nakao S; Hess AD
Bone Marrow Transplant; 2003 Oct; 32(8):785-90. PubMed ID: 14520422
[TBL] [Abstract][Full Text] [Related]
12. Early viral complications after autologous CD34-selected peripheral blood stem cell transplantation.
Sica S; Sora F; Chiusolo P; Laurenti L; Cattani P; Giordano G; Piccirillo N; Ortu La Barbera E; Leone G
Bone Marrow Transplant; 2000 Sep; 26(5):587-8. PubMed ID: 11019854
[No Abstract] [Full Text] [Related]
13. Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation.
Frère P; Pereira M; Fillet G; Beguin Y
Eur J Haematol; 2006 Feb; 76(2):102-8. PubMed ID: 16405430
[TBL] [Abstract][Full Text] [Related]
14. Human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in adult allogeneic hematopoietic stem cell transplant recipients and immune control of viral infection.
Lilleri D; Fornara C; Chiesa A; Caldera D; Alessandrino EP; Gerna G
Haematologica; 2008 Feb; 93(2):248-56. PubMed ID: 18245650
[TBL] [Abstract][Full Text] [Related]
15. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
Kasow KA; Sims-Poston L; Eldridge P; Hale GA
Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
[TBL] [Abstract][Full Text] [Related]
16. Higher infused CD34+ hematopoietic stem cell dose correlates with earlier lymphocyte recovery and better clinical outcome after autologous stem cell transplantation in non-Hodgkin's lymphoma.
Yoon DH; Sohn BS; Jang G; Kim EK; Kang BW; Kim C; Kim JE; Kim S; Lee DH; Lee JS; Park SJ; Park CJ; Huh J; Suh C
Transfusion; 2009 Sep; 49(9):1890-900. PubMed ID: 19453991
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy.
Peggs KS; Mackinnon S
Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456
[TBL] [Abstract][Full Text] [Related]
18. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease.
Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R
Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous rupture of the spleen as immediate complication in autologous transplantation for primary systemic amyloidosis.
Fernández de Larrea C; Cibeira MT; Rovira M; Rosiñol L; Esteve J; Bladé J
Eur J Haematol; 2008 Feb; 80(2):182-4. PubMed ID: 18081703
[TBL] [Abstract][Full Text] [Related]
20. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]